Jordan Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jordan Healthcare Press.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 27, 2026

Mar. 27, 2026

Lighthouse Autism Center Opening New Autism Therapy Center in Asheboro, North Carolina

GlobeNewswire

Mar. 27, 2026

SafeSpace Global to Attend NIC Spring Conference to Engage Senior Living and Healthcare Leaders

GlobeNewswire

Mar. 27, 2026

Navigator Medicines Advances NAV-240 into Phase 2a and NAV-242 into the Clinic, Supported by New Positive Data Presented at American Academy of Dermatology (AAD) Annual Meeting 2026

GlobeNewswire

Mar. 27, 2026

Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics

GlobeNewswire

Mar. 27, 2026

First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement

GlobeNewswire

Mar. 27, 2026

Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update

GlobeNewswire

Mar. 27, 2026

Axe Compute to Host Annual Report Conference Call

GlobeNewswire

Mar. 27, 2026

Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood Test

GlobeNewswire

Mar. 27, 2026

ORIC® Pharmaceuticals to Report Combination Dose Optimization Data From Phase 1b Trial of Rinzimetostat in Patients with mCRPC

GlobeNewswire

Mar. 27, 2026

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2

GlobeNewswire

Mar. 27, 2026

Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones

GlobeNewswire

Mar. 27, 2026

Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma

GlobeNewswire

Mar. 27, 2026

Communiqué de presse : La formulation sous-cutanée de Sarclisa de Sanofi, administrée via un injecteur portable, est recommandée par le CHMP pour approbation dans l'UE dans le traitement du myélome multiple

GlobeNewswire

Mar. 27, 2026

OXB recognised as ‘Most Innovative CDMO (Cell & Gene)’ at 2026 CDMO Leadership Awards

GlobeNewswire

Mar. 27, 2026

Vor Bio Announces $75 Million Private Placement with TCGX

GlobeNewswire

Mar. 27, 2026

ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy® 1 mg (epinephrine nasal spray) Label

GlobeNewswire

Mar. 27, 2026

OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies

GlobeNewswire

Mar. 27, 2026

Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

GlobeNewswire

Mar. 27, 2026

Arletta Pharma Solutions Announces Positive Results from Phase II Clitoral Doppler Duplex Ultrasound Study of Lybrido™ Combination Targeting Female Sexual Dysfunction

GlobeNewswire

Mar. 27, 2026

Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone

GlobeNewswire